Condition
Viral Pneumonia Human Coronavirus
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Completed2
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04636671Phase 3Completed
Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)
NCT04336345Completed
Outcomes of Patients With COVID-19 in the Intensive Care Unit
NCT04344288Phase 2TerminatedPrimary
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
NCT04394208Phase 3Unknown
Silymarin in COVID-19 Pneumonia
Showing all 4 trials